Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

diabetes-777001_960_720

Study reveals “concerning” low standards of type 2 diabetes drugs in India

March 7, 2018
Research and Development India, diabetes, pharma, regulatory, type 2 diabetes

In what they believe is the first study of its kind, a team of researchers at the University of Massachusetts …

News
diabetes-2424105_960_720

Study identifies five kinds of diabetes, potentially changing treatment

March 2, 2018
Medical Communications, Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

A decade-long study has unearthed findings that could entirely change how people living with diabetes are treated, after the classic …

News

Novo Nordisk delivers in much-anticipated oral semaglutide diabetes trial

February 23, 2018
Medical Communications, Research and Development Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes

Novo Nordisk has lifted the curtain on much-anticipated results data from the first of ten Phase 3 trials into the …

News
shutterstock_273326141

Roivant signs $600m licensing deal with Poxel

February 13, 2018
Manufacturing and Production, Sales and Marketing Poxel, Roivant, diabetes, imeglimin, pharma

Roivant Sciences has announced that it has entered into a licensing partnership with Poxel to develop and commercialise the latter’s …

News

Novo’s Ozempic secures European approval in type 2 diabetes

February 12, 2018
Sales and Marketing EC, EMA, Europe, Novo Nordisk, diabetes, pharma

Novo Nordisk has revealed that its drug Ozempic (semaglutide) has received approval from the European Commission (EC) as a monotherapy …

News
merck_and_co

MSD and Pfizer receive approval for combo diabetes therapy

December 21, 2017
Sales and Marketing MSD, Pfizer, biotech, diabetes, drugs, pharma, pharmaceutical

MSD (known as Merck in North America) and Pfizer have announced that their sodium-glucose co-transporter 2 (SGLT2) inhibitor has received …

News
shutterstock_138095450

Novartis, Abbott targeted by Indian watchdog over allegations of price collusion

December 14, 2017
Sales and Marketing Abbott, Emcure Pharma, Galdus, Novartis, USV, diabetes, pharma, vildagliptin

Novartis, Abbott, Emcure Pharma and USV have become the targets of an investigation by the Competition Commission of India (CCI) …

News
fdaoutsideweb

FDA approves first short-acting, follow-on biologic of Lilly’s Humalog insulin product

December 12, 2017
Manufacturing and Production, Sales and Marketing Admelog, FDA, Humalog, Sanofi, diabetes, insulin, pharma

The FDA has announced its approval of Sanofi’s Admelog (insulin lispro), the first follow-on biologic version of Eli Lilly’s Humalog …

News
diabetes-2424105_960_720

Study reveals diet able to reverse diabetes in half of patients

December 6, 2017
Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

Building on their previous research emerging from Professor Roy Taylor’s work at Newcastle University, a study has found that 45.6% …

News
novo_flag

Novo Nordisk unveils hard-hitting data for two of its diabetes therapies

December 5, 2017
Manufacturing and Production, Research and Development Novo Nordisk, Tresiba, Xultophy, diabetes, pharma

Novo Nordisk has lifted the curtain on new data from two of its therapies for diabetes, Xultophy (insulin degludec/liraglutide) and …

News
diabetes-2424105_960_720

Type 1 diabetes misunderstood as “disease of childhood”

December 1, 2017
Medical Communications biotech, diabetes, drugs, pharma, pharmaceutical

New research published in The Lancet has revealed that type 1 diabetes cannot be understood as a “disease of the …

News

Psoriasis patients at greater risk of type 2 diabetes, study reveals

November 15, 2017
Research and Development diabetes, pharma, psoriasis, type 2 diabetes

Researchers at the University of Pennsylvania’s Perelman School of Medicine have discovered that people with psoriasis are more at risk …

News

Sanofi Q3 results disappoint due to waning diabetes sales

November 2, 2017
Sales and Marketing Lantus, Sanofi, diabetes, pharma

Sanofi readjusted its 2017 financial expectations after its third-quarter results came in lower than projected. The company revealed that net …

News

Sanofi launches patent infringement lawsuit against Mylan over diabetes pen

October 25, 2017
Research and Development, Sales and Marketing Basaglar, Eli Lilly, Lantus, Mylan, Sanofi, diabetes, insulin, patent infringement, pharma

Sanofi has launched a lawsuit against Mylan as part of a dispute that alleges that the latter infringed upon 18 …

News
diabetes-2424105_960_720

Type 3 diabetes more common than Type 1 and often misdiagnosed

October 25, 2017
Research and Development biotech, diabetes, drugs, pharma, pharmaceutical

In the first ever study of its kind, researchers from the University of Surrey examined the records of more than …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026